(Q51561383)

English

Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution.

scientific article published in August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution. (English)

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

0 references

1 reference

based on heuristic

inferred from title

author name string

Feldman M

1

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

Cryer B

2

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

language of work or name

0 references

publication date

1 August 1999

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

American Journal of Cardiology

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

84

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

4

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

404-409

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

Aspirin as an antiplatelet drug

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900324-0

7 January 2021

Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900324-0

7 January 2021

Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900324-0

7 January 2021

Dose effects of aspirin on gastric prostaglandins and stomach mucosal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900324-0

7 January 2021

The antiplatelet effects of ticlopidine and clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900324-0

7 January 2021

Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900324-0

7 January 2021

Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900324-0

7 January 2021

Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Thrombolysis--the preferred treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900324-0

7 January 2021

Thrombolysis in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900324-0

7 January 2021

Identifiers

10.1016/S0002-9149(99)00324-0

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/10468077

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51561383&oldid=1371372526"